Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A computational approach to aid clinicians in selecting anti-viral drugs for COVID-19 trials.

Scientific reports - 27 Apr 2021

Mongia Aanchal, Saha Sanjay Kr, Chouzenoux Emilie, Majumdar Angshul

Abstract excerpt

The year 2020 witnessed a heavy death toll due to COVID-19, calling for a global emergency. The continuous ongoing research and clinical trials paved the way for vaccines. But, the vaccine efficacy in the long run is still questionable due to the mutating coronavirus, which makes drug re-positioning a reasonable alternative. COVID-19 has hence fast-paced drug re-positioning for the treatment of COVID-19 and its...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Area Under Curve
Share to COVID-19

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to COVID-19 Drug Treatment

Share to Databases, Factual

Share to Drug Repositioning

Share to ROC Curve

Share to SARS-CoV-2

Source

Open in PubMed Open full text

Identifiers

PMID: 33907209
DOI: 10.1038/s41598-021-88153-3
PMCID: PMC8079380

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A computational approach to aid clinicians in selecting anti-viral drugs for COVID-19 trials.PMID 33907209Read ↗

Computational Approaches to Assist Drug Repositioning for COVID-19Semantic proximity Read ↗

Computational drug repositioning using similarity constrained weight regularization matrix factorization: A case of COVID ‐19Semantic proximity Read ↗

Computational drug re-purposing targeting the spike glycoprotein of SARS-CoV-2 as an effective strategy to neutralize COVID-19Semantic proximity Read ↗

Optimizing Antiviral Therapy for COVID-19 With Learned Pathogenic ModelSemantic proximity Read ↗

Translating GWAS Findings to Inform Drug Repositioning Strategies for COVID-19 TreatmentSemantic proximity Read ↗

A Comprehensive Review of Drug Repurposing Strategies against Known Drug Targets of COVID-19Semantic proximity Read ↗

A Hybrid AI-driven Algorithm to Uncover Potential Therapeutic Targets for COVID-19 Using Network-based Drug RepurposingSemantic proximity Read ↗

Profiling Molecular Simulations of SARS-CoV-2 Main Protease (Mpro) Binding to Repurposed Drugs Using Neural Network Force FieldsSemantic proximity Read ↗

Systematic Down-Selection of Repurposed Drug Candidates for COVID-19Semantic proximity Read ↗

Network bioinformatics analysis provides insight into drug repurposing for COVID-19Semantic proximity Read ↗

Drug Repurposing of potential drug targets for treatment of COVID-19Semantic proximity Read ↗

Combined Deep Learning and Molecular Docking Simulations Approach Identifies Potentially Effective FDA Approved Drugs for Repurposing Against SARS-CoV-2Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.